BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 228200)

  • 1. Purified cardiac cell membranes with high (Na+ + K+)ATPase activity contain significant NADH-vanadate reductase activity.
    Erdmann E; Krawietz W; Philipp G; Hackbarth I; Schmitz W; Scholz H; Crane FL
    Nature; 1979 Nov; 282(5736):335-6. PubMed ID: 228200
    [No Abstract]   [Full Text] [Related]  

  • 2. [NADH-vanadate-oxidoreductase in emotional-pain stress and its possible role in the regulation of Na+-K+-ATPase activity].
    Iakushev VS; Makoed OB; Davydov VV; Shkopinskiĭ EA
    Ukr Biokhim Zh (1978); 1985; 57(6):34-8. PubMed ID: 3000037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of NADH-vanadate-oxidoreductase of cardiac and erythrocyte cell membranes.
    Erdmann E; Werdan K; Krawietz W; Lebuhn M; Christl S
    Basic Res Cardiol; 1980; 75(3):460-5. PubMed ID: 6255934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of rat cardiac and renal Na+,K+-ATPase by high sodium concentrations and vanadate.
    Clough DL
    Life Sci; 1985 Sep; 37(9):799-807. PubMed ID: 2993776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vanadate on ouabain binding and inhibition of (Na+ + K+)-ATPase.
    Myers TD; Boerth RC; Post RL
    Biochim Biophys Acta; 1979 Nov; 558(1):99-107. PubMed ID: 227460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanadate inhibition of Na+K+. ATPase and K+-dependent p-nitrophenylphosphatase: a kinetic analysis.
    Blázovics A; Vodnyánszky L; Somogyi J; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1983; 18(3-4):199-209. PubMed ID: 6331047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of (Na,K)-ATPase by tetravalent vanadium.
    North P; Post RL
    J Biol Chem; 1984 Apr; 259(8):4971-8. PubMed ID: 6325413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanadium, Na-K-ATPase, and potassium adaptation in the rat.
    Higashino H; Bogden JD; Lavenhar MA; Bauman JW; Hirotsu T; Aviv A
    Am J Physiol; 1983 Feb; 244(2):F105-11. PubMed ID: 6297310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic side.
    Cantley LC; Resh MD; Guidotti G
    Nature; 1978 Apr; 272(5653):552-4. PubMed ID: 211419
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions of ouabain and vanadate with (Na+,K+)ATPase and isolated cardiac muscle.
    Myers TD; Boerth RC
    Biochem Biophys Res Commun; 1980 Sep; 96(1):39-46. PubMed ID: 6254511
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition by vanadate of the reactions catalyzed by the (Na+ + K+)-stimulated ATPase. A transient state kinetic characterization.
    Hobbs AS; Froehlich JP; Albers RW
    J Biol Chem; 1980 Jun; 255(12):5724-7. PubMed ID: 6247343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dog kidney (Na+,K+)-ATPase is more sensitive to inhibition by vanadate than human red cell (Na+,K+)-ATPase.
    Bond GH; Hudgins PM
    Biochim Biophys Acta; 1981 Sep; 646(3):479-82. PubMed ID: 6269617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of several ligands on the potassium-vanadate interaction in the inhibition of the (Na+ + K+)-ATPase and the Na+, K+ pump.
    Beaugé L; Berberian G
    Biochim Biophys Acta; 1983 Jan; 727(2):336-50. PubMed ID: 6301556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanadate inhibits mevalonate synthesis and activates NADH oxidation in microsomes.
    Menon AS; Rau M; Ramasarma T; Crane FL
    FEBS Lett; 1980 May; 114(1):139-41. PubMed ID: 6900565
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation.
    Erdmann E; Krawietz W; Phillipp G; Hackbarth I; Schmitz W; Scholz H
    Nature; 1979 Mar; 278(5703):459-61. PubMed ID: 221820
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition by vanadium of sodium and potassium dependent adenosinetriphosphatase derived from animal and human tissues.
    Nechay BR; Saunders JP
    J Environ Pathol Toxicol; 1978; 2(2):247-62. PubMed ID: 216760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanadate-stimulated NADH oxidation in plasma membrane.
    Ramasarma T; MacKellar WC; Crane FL
    Biochim Biophys Acta; 1981 Aug; 646(1):88-98. PubMed ID: 6912071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-affinity Na+ sites on (Na+ +K+)-ATPase modulate inhibition of Na+-ATPase activity by vanadate.
    Bond GH; Hudgins PM
    Biochim Biophys Acta; 1982 May; 687(2):310-4. PubMed ID: 6284222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulatory effect of vanadate on the adenylate cyclase of cardiac tissue.
    Krawietz W; Werdan K; Erdmann E
    Biochem Pharmacol; 1979 Aug; 28(16):2517-20. PubMed ID: 228676
    [No Abstract]   [Full Text] [Related]  

  • 20. The fate of cytoplasmic vanadium. Implications on (NA,K)-ATPase inhibition.
    Cantley LC; Aisen P
    J Biol Chem; 1979 Mar; 254(6):1781-4. PubMed ID: 217870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.